期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
人PRX3原核表达质粒的构建及表达
1
作者 冯艳 刘钊 宋伯根 《同济大学学报(医学版)》 CAS 2006年第5期21-23,30,共4页
目的构建人Peroxiredoxin 3(PRX3)原核表达质粒,并在大肠杆菌中进行表达。方法采用基因工程技术将PRX3编码序列插入原核表达质粒载体pET-30(a),再将重组质粒转化大肠杆菌BL21(DE3),IPTG诱导表达,并对表达产物进行SDS-PAGE分析。结果酶... 目的构建人Peroxiredoxin 3(PRX3)原核表达质粒,并在大肠杆菌中进行表达。方法采用基因工程技术将PRX3编码序列插入原核表达质粒载体pET-30(a),再将重组质粒转化大肠杆菌BL21(DE3),IPTG诱导表达,并对表达产物进行SDS-PAGE分析。结果酶切鉴定和DNA测序证实人PRX3编码序列全长正确地插入表达质粒中,序列与GenBank报道的一致;重组PRX3在大肠杆菌获得高效表达,且易形成包涵体。结论人PRX3原核表达质粒构建成功,并能在大肠杆菌中高效表达,为后续研究奠定了良好基础。 展开更多
关键词 prx3 DNA重组 基因表达
下载PDF
Construction of Eukaryotic Expression Plasmid of Human PRX3 and Its Expression in HEK-293FT Cells 被引量:1
2
作者 冯艳 刘钊 +4 位作者 曹慧青 孟宪敏 瞿智玲 熊密 邓仲端 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2004年第4期311-313,321,共4页
To construct the eukaryotic expression plasmid of human PRX3 and measure its expression in the HEK-293FT cells, the full-length coding region of human PRX3 was cloned by PCR and inserted into the eukaryotic expression... To construct the eukaryotic expression plasmid of human PRX3 and measure its expression in the HEK-293FT cells, the full-length coding region of human PRX3 was cloned by PCR and inserted into the eukaryotic expression vector pcDNA4-Xpress (A). HEK-293FT cells were transiently transfected with the recombinant plasmid. Western blot and immuofluorescence were used to detect the expression of the fusion protein. In the experiment, restriction analysis identified the construction of the recombinant plasmid and the inserted sequence was identical with that published on GenBank. Western blot and immunofluorescence confirmed the expression of the recombinant protein in transfected HEK-293FT cells. It was concluded that the eukaryotic expression plasmid of human PRX3 was constructed successfully and the recombinant could be expressed efficiently in HEK-293FT cells, which provides a sound basis for the further study on human PRX3. 展开更多
关键词 prx3 molecular cloning TRANSFECTION gene expression
下载PDF
Formaldehyde Induces the Bone Marrow Toxicity in Mice by Regulating the Expression of Prx3 Protein
3
作者 于光艳 宋祥福 +2 位作者 赵淑华 刘颖 孙志伟 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2015年第1期82-86,共5页
Formaldehyde(FA) is a ubiquitous toxic organic compound, and it has been regarded as a leukemogen. However, the mechanisms by which FA induces bone marrow toxicity remain unclear. The present study was aimed to exam... Formaldehyde(FA) is a ubiquitous toxic organic compound, and it has been regarded as a leukemogen. However, the mechanisms by which FA induces bone marrow toxicity remain unclear. The present study was aimed to examine the bone marrow toxicity caused by FA and the mechanism involving the expression changes of peroxiredoxin3(Prx3) in this process. The mice were divided into four groups with 6 mice per group. Animals in the control group were exposed to ambient air and those in the FA groups to different concentrations of FA(20, 40, 80 mg/m3) for 15 days in the separate inhalation chambers, 2 h a day. At the end of the 15-day experimental period, all mice were killed. Bone marrow cells were obtained. The level of hydrogen peroxide(H2O2), the apoptosis rate, and the activities and protein expression levels of caspase-3 and caspase-9 were determined by biochemical assay, flow cytometry and immunohistochemistry, respectively; DNA damage and Prx3 expression levels were measured by single cell gel eletrophoresis immunohistochemistry and Western blotting, respectively. The results showed that the H2O2 level and cell apoptosis rate were significantly increased in FA groups relative to the control group. Caspase-3 and caspase-9 activities and their protein expression levels were markedly increased as well. Additionally, FA also increased the rate of DNA damage and the expression level of Prx3 compared with control group. Our study suggested that a certain concentration of FA causes the bone marrow toxicity by regulating the expression of Prx3. 展开更多
关键词 FORMALDEHYDE H2O2 apoptosis DNA prx3
下载PDF
血清miR-200a与过氧化物还原酶水平对晚期三阴性乳腺癌患者预后的预测价值
4
作者 王庆 陈胜洲 +1 位作者 吴志红 倪俊刚 《中国妇幼保健》 CAS 2023年第20期3847-3850,共4页
目的分析血清miR-200a与过氧化物还原酶(PRX3)水平对晚期三阴性乳腺癌患者预后的预测价值。方法选取2021年1月—2022年12月义乌市中心医院收治的80例晚期三阴性乳腺癌患者为研究对象,入选患者均采取相同的化疗方案,并根据化疗效果分为... 目的分析血清miR-200a与过氧化物还原酶(PRX3)水平对晚期三阴性乳腺癌患者预后的预测价值。方法选取2021年1月—2022年12月义乌市中心医院收治的80例晚期三阴性乳腺癌患者为研究对象,入选患者均采取相同的化疗方案,并根据化疗效果分为观察组(完全缓解、部分缓解,共计45例)与对照组(稳定、进展,共计35例)。两组均行血清miR-200a与PRX3检测,比较两组检测结果差异;同时根据该组患者有无血清miR-200a、PRX3表达,分为miR-200a阳性组与miR-200a阴性组,PRX3阳性组与PRX3阴性组,比较不同组别无进展生存期、1年存活率的差异;最后通过相关性分析,分析血清miR-200a、PRX3水平与晚期三阴性乳腺癌患者预后情况的相关性。结果观察组与对照组患者血清miR-200a阳性率分别为13.3%和57.1%,血清PRX3阳性率分别为11.1%和51.4%,观察组血清miR-200a与PRX3阳性率均低于对照组(P<0.05);miR-200a阳性组与miR-200a阴性组无进展生存期分别为(6.5±1.8)月和(9.8±2.3)月,1年存活率分别为46.2%和66.7%,miR-200a阳性组的无进展生存期与1年存活率均低于miR-200a阴性组(均P<0.05);PRX3阳性组与PRX3阴性组无进展生存期分别为(6.3±1.5)月和(9.6±2.4)月,1年存活率分别为47.8%和64.9%,PRX3阳性组无进展生存期与1年存活率均低于PRX3阴性组(均P<0.05);通过相关性分析发现,血清miR-200a阳性、PRX3阳性与晚期三阴性乳腺癌患者预后情况存在相关性(r值为5.231、6.854,P值为0.001、0.001)。结论血清miR-200a阳性、PRX3阳性与晚期三阴性乳腺癌患者预后情况存在相关性,血清miR-200a与PRX3阳性的晚期三阴性乳腺癌患者预后情况更差,说明血清miR-200a与PRX3有着较好的预测价值,可推广使用。 展开更多
关键词 血清miR-200a 过氧化物还原酶 晚期三阴性乳腺癌 预后预测 无进展生存期 1年存活率
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部